- AdventHealth
“When you go, you realize the impact (you can have),” said Dr. Rajendra Sawh-Martinez, a pediatric plastic surgeon at AdventHealth for Children who started his medical mission trip journey while still in medical school.
Dr. Raj, as he’s known, got emotional while talking about his recent medical mission trip to Mexico helping improve the lives of children with facial detects.
“People have very strong stigmas against these poor children … who are born with a deformity that’s front and center. It’s their face, it’s their lip, it’s their nose and through a couple of hours in a day we can change their entire life,” said Dr. Raj.
When the doctors travel on these trips, they go in large groups with nurses and other volunteers and often bring their own medical equipment. The teams go to Central & South America, the Caribbean and Mexico. The trips involve long days – surgeries start at 7 am and they work until sunset.
Globally, the Sharing Smiles program has transformed the lives of more than 26,000 people by providing hope and healing to disadvantaged children through free, quality health care. The program partners with the host country to provide smiles three ways:
- cleft lip and palate treatment
- comprehensive dentistry
- individualized pediatric rehabilitation
Dr. Dobson, an anesthesiologist for AdventHealth Orlando, says it’s truly a labor of love. He has donated his time and expertise with Sharing Smiles since the late 1980s.
“I can’t give them clean water. I don’t know how to give them electricity, but I can go out and put them to sleep and wake them up. I can be part of a team that helps them have a better life,” said Dr. Dobson.
During the most recent mission trip to Bolivia in April 2023, AdventHealth physicians were part of the Sharing Smiles team that screened 60 children and conducted 38 successful facial reconstructions.
To learn more about Sharing Smiles and how you can get involved, click here.
Watch the full FOX 35 News story featuring Dr. Dobson and Dr. Raj here.
Recent News
AdventHealth Cancer Institute Advances the Use of CAR T-Cell Therapy for Multiple Myeloma
CAR-T therapies have emerged as new treatment options for certain types of cancer through a one-time infusion that can lead to long-lasting remission.
AdventHealth Graduate Medical Education Program Celebrates 50 Years
Growing from a family practice residency to 24 accredited programs, AdventHealth’s Graduate Medical Education (GME) program celebrates 50 years.
New Clinical Trial Explores Digital Intervention for Apathy in Late-life Depression
Afflicting 30-50% of patients with late-life depression, apathy is a challenging psychiatric syndrome in older adulthood that can result in lack of motivation leading to poor self-care, physical...
AdventHealth Performs Central Florida’s First Liver Transplant for Unresectable Colorectal Liver Metastases
In June 2025, AdventHealth Abdominal Transplant Surgeon and Surgical Oncologist Ryan Day, MD, worked with a multidisciplinary team to perform Central Florida’s first liver transplant for unresectable...
AdventHealth Neuroscience Institute First in Florida to be Recognized as a GammaTile Center of Excellence
GammaTile is the first and only tile-based radiation therapy for the treatment of
operable brain tumors. The AdventHealth Neuroscience Institute began performing GammaTile procedures in 2021 and was...
An AdventHealth Collaboration Explores the Impact of Microgravity and Electrical Stimulation on Muscle Cell Health in Space
Using a muscle lab-on-chip model aboard the International Space Station (ISS), AdventHealth Translational Research Institute’s Dr. Paul Coen has been working with a multidisciplinary team from the...
AdventHealth Neuroscience Institute Among First in U.S. to Offer Phase IIa Clinical Trial of Troculeucel for Moderate Alzheimer’s Disease
While most clinical trials for Alzheimer’s disease have focused on patients with early or mild cognitive impairment, roughly 30% of those with Alzheimer’s have moderate stage disease for which there...
AdventHealth Translational Research Institute Selected as Clinical Site for National Study of Muscle, Mobility and Aging (SOMMA)
Under the leadership of Scientific Director and Principal Investigator Bret H. Goodpaster, PhD, the AdventHealth Translational Research Institute (TRI) is now enrolling men and women 70 years of age...
AdventHealth Neuroscience Institute Administers First Dose of Investigative NK Cell Therapy to Person with Alzheimer’s Disease
Under a single compassionate use Investigational New Drug (IND) authorization cleared by the U.S. Food and Drug Administration (FDA), the AdventHealth Neuroscience Institute worked with NKGen Biotech...
New Study Published in the New England Journal of Medicine Shows the Addition of Regional Nodal Irradiation Does Not Decrease Rate of Invasive Breast Cancer Recurrence in Patients with Negative Axillary Nodes Following Neoadjuvant Chemotherapy
Findings of the phase III, multicenter, randomized NSABP B-51-RTOG 1304 clinical trial were recently published in the New England Journal of Medicine with AdventHealth Cancer Institute’s Dr. Mamounas...
AdventHealth Study Exploring the Use of MR-Guided Focused Ultrasound (MRgFUS) to Disrupt the Blood-Brain Barrier for Treatment of Alzheimer’s Disease
Under the leadership of Dr. Valeria Baldivieso and Dr. Chandan Reddy, the AdventHealth Research Institute is the first and only site in Orlando offering the Exablate Blood-Brain Barrier (BBB)...
AdventHealth Research Institute Offers Phase II Clinical Trial of Etanercept for Treatment of Blast-Induced Tinnitus
Approximately 1 billion people throughout the world suffer from tinnitus (ringing in the ears), and it is the number one disability of those who serve in the U.S. military. The condition can disrupt...